LSE - Delayed Quote • GBp
e-therapeutics plc (ETX.L)
At close: April 25 at 5:15 PM GMT+1
Breakdown
TTM
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
-10,154.00
-8,011.00
-7,799.00
-3,358.00
Investing Cash Flow
588.00
15,308.00
-9,941.00
-5,068.00
Financing Cash Flow
12,850.00
13,046.00
22,332.00
12,598.00
End Cash Position
24,845.00
31,689.00
11,346.00
7,005.00
Capital Expenditure
-184.00
-210.00
-963.00
-71.00
Issuance of Capital Stock
13,451.00
13,437.00
21,669.00
12,644.00
Free Cash Flow
-10,338.00
-8,221.00
-8,762.00
-3,429.00
1/31/2021 - 11/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVG.L Evgen Pharma plc
0.8000
0.00%
FAB.L Fusion Antibodies plc
3.7500
0.00%
FARN.L Faron Pharmaceuticals Oy
127.50
0.00%
C4XD.L C4X Discovery Holdings plc
12.00
+27.32%
REDX.L Redx Pharma Plc
10.00
+8.11%
BAI.AS BenevolentAI S.A.
0.6800
-6.85%
FUM.L Futura Medical plc
35.40
-1.12%
SLN Silence Therapeutics plc
21.62
-2.92%
PHM.MC Pharma Mar, S.A.
28.82
+1.41%
SAR.L Sareum Holdings plc
26.25
-13.93%